Corpovael, S.A.B. de C.V.

Total Valuation

Corpovael, S.A.B. de C.V. carries a market capitalization of 2.19B, placing it among publicly traded companies globally. Its enterprise value stands at 3.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Corpovael, S.A.B. de C.V. currently has 292.64M shares outstanding.

Valuation Ratios

Corpovael, S.A.B. de C.V. trades at a trailing price-to-earnings ratio of 6.64. The price-to-sales ratio is 0.54, and the price-to-book ratio stands at 0.46.

Enterprise Valuation

On an enterprise value basis, Corpovael, S.A.B. de C.V. trades at an EV/EBITDA multiple of 10.86 and an EV/FCF ratio of 19.91. The EV/Sales ratio of 1.04 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.86 provides insight into valuation relative to core operating earnings.

Financial Position

Corpovael, S.A.B. de C.V. maintains a current ratio of 2.38, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 39.43, indicating elevated leverage, while an interest coverage ratio of 6.45 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Corpovael, S.A.B. de C.V. posts a return on equity of 7.21 and a return on invested capital of 4.17.

Taxes

Over the trailing twelve months, Corpovael, S.A.B. de C.V. has paid 22.75M in income taxes, reflecting an effective tax rate of 6.91.

Stock Price Statistics

Corpovael, S.A.B. de C.V.'s stock has gained approximately 133.75% over the past 52 weeks. The 50-day moving average sits at 7.78, while the 200-day moving average is 5.58.

Income Statement

Over the trailing twelve months, Corpovael, S.A.B. de C.V. generated 3.80B in revenue and converted that into 306.96M in net income, yielding earnings per share of 1.02. EBITDA reached 363.45M, while operating income came in at 363.45M.

Balance Sheet

Corpovael, S.A.B. de C.V. holds 469.03M in cash and equivalents against 2.33B in total debt, resulting in a net debt position of 1.85B. Total book value stands at 4.47B, with working capital of 3.28B providing operational flexibility.

Cash Flow

Corpovael, S.A.B. de C.V. produced 142.92M in operating cash flow over the past twelve months. After subtracting -2.92M in capital expenditures, free cash flow totaled 140.00M - equivalent to 0.47 per share.

Margins

Corpovael, S.A.B. de C.V. operates with a gross margin of 22.83, reflecting its pricing power and cost economics. The operating margin of 9.56 and net profit margin of 8.08 provide insight into operational efficiency.

Dividends & Yields

Scores

Corpovael, S.A.B. de C.V. posts an Altman Z-Score of 1.41, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.